ArticlemAbs
5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia.
May Kung Sutherland et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
cites it